Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Medtec Expo 2015: Novel tissue substitute made of high-tech fibers

01.04.2015

Regenerative medicine uses cells harvested from the patient’s own body to heal damaged tissue. Fraunhofer researchers have developed a cell-free substrate containing proteins to which autologous cells bind and grow only after implantation. Samples of the new implants will be on show at the Medtec expo.

Donor organs or synthetic implants are usually the only treatment option for patients who have suffered irreparable damage to internal organs or body tissue. But such transplants are often rejected. Implants based on autologous cells are more likely to be accepted by the human organism.


The high-tech fibrous material can be used to replace human tissue.

© Fraunhofer IGB

But in order to grow, these cells require a compatible structural framework. Researchers at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB in Stuttgart are working on a project to develop suitable substrates – known as scaffolds – in collaboration with the university hospital in Tübingen and the University of California, Los Angeles (UCLA).

Their solution is based on electrospinning, a process in which synthetic and biodegradable polymers such as polylactides are spun into fibers using an electrical charge. These fibers are then used to create a three-dimensional non-woven fabric.

Growing cells inside the patient’s body

The scientists have chosen a novel approach in which proteins are added to the polymeric material during the electrospinning process, and become incorporated in the resulting hair-thin fibers. In this way, the material serves as a substrate to which the patient’s own cells will bind after it has been implanted.

“Electrospinning enables us to create a cell-free substrate on which cells can grow after it has been implanted in the patient’s body. Each type of protein attracts specific cells, which adhere to the scaffold and grow there. By selecting the appropriate protein, we can build up heart tissue or regenerate other damaged organs,” explains Dr. Svenja Hinderer, one of the research scientists working on this project at Fraunhofer IGB in Stuttgart.

The substrate is spun into a fine sheet and cut to the required size. To repair damage to the heart muscle, for instance, a scaffold corresponding to the extent of the damaged area is placed like a blanket over the muscular tissue.

The polymeric fibers gradually degrade in the human organism over a period of approximately 48 months. During this time, the cells that bind to the proteins find an environment that is conducive to their growth. They construct their own matrix and restore the functions of the original tissue.

Successful bioreactor test results

The results of initial laboratory experiments and bioreactor tests have been very successful so far. The researchers have been able to demonstrate that esophageal/tracheal cells, which are difficult to culture in-vitro, are capable of binding to decorin protein fibers in the substrate and growing there. Another protein – the stromal-cell derived growth factor SDF-1 – binds with progenitor cells, a special type of stem cell necessary for constructing heart valves and for regenerating heart muscle cells after an infarction.

“The implants we have fabricated using electrospinning demonstrate the same mechanical and structural properties as a normal heart valve. Like the original version, they close and open at a blood pressure of 120 to 80 mmHg during tests in a bioreactor,” says Hinderer. The next step for the researcher and her colleagues is to test the protein-coated scaffolds in animal models.

The hybrid materials composed of polymeric and protein fibers can be produced and stored in large quantities. The IGB team is working to bring the novel substrate to market as a rapidly implementable alternative to conventional heart valve replacements.

“We can’t yet say how long this will take, though,” comments the researcher. One of the advantages of cell-free implants is that they are classified as medical devices and not as novel therapeutic drugs, which means less time waiting for approval.

“Even so, the process of obtaining approval for medical devices that are populated with human cells prior to implantation is very long and expensive,” explains Hinderer. The researchers will be presenting samples of the polymeric scaffolds at the Medtec expo in Stuttgart from April 21 to 23, in the joint Fraunhofer booth (Hall 7, Booths 7B04/7B10). Exhibits also include a bioreactor for cell culture on these substrates.

Dr. Claudia Vorbeck | Fraunhofer Research News

More articles from Trade Fair News:

nachricht New VDI standards established for cleanroom technology
11.09.2017 | Fraunhofer-Institut für Produktionstechnik und Automatisierung IPA

nachricht Cleaning is just the beginning
11.09.2017 | Fraunhofer-Institut für Produktionstechnik und Automatisierung IPA

All articles from Trade Fair News >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Glycosylation: Mapping Uncharted Territory

21.09.2017 | Life Sciences

Highly precise wiring in the Cerebral Cortex

21.09.2017 | Health and Medicine

Did marine sponges trigger the ‘Cambrian explosion’ through ‘ecosystem engineering’?

21.09.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>